Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | ― | ― | -3.80K | -2.42K | -13.09K | ― |
EBITDA | ― | ― | -13.18M | -6.21M | -3.35M | -1.51M |
Net Income | ― | ― | -13.27M | -5.43M | -3.35M | -1.54M |
Balance Sheet | ||||||
Total Assets | 2.83M | 1.54M | 5.20M | 4.30M | 7.09M | 597.40K |
Cash, Cash Equivalents and Short-Term Investments | 987.20K | 826.85K | 4.05M | 2.70M | 6.89M | 234.96K |
Total Debt | 1.81K | 0.00 | 2.22M | 0.00 | 98.76K | 31.62K |
Total Liabilities | 10.05M | 7.42M | 7.26M | 1.35M | 1.77M | 737.20K |
Stockholders Equity | -7.23M | -5.88M | -2.05M | 2.95M | 5.32M | ― |
Cash Flow | ||||||
Free Cash Flow | ― | -9.49M | -7.70M | -5.47M | -1.61M | -1.20M |
Operating Cash Flow | ― | -9.49M | -7.70M | -5.47M | -1.60M | -1.20M |
Investing Cash Flow | 0.00 | 0.00 | -5.92K | -1.67K | -18.11K | -132.67K |
Financing Cash Flow | 551.81K | 6.21M | 9.32M | 2.15M | 7.83M | 963.31K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $45.34M | ― | -276.15% | ― | 41.54% | 42.59% | |
59 Neutral | £5.92B | 9.22 | -57.69% | 5.52% | 15.15% | -9.83% | |
54 Neutral | $61.76M | ― | -71.64% | ― | -98.90% | -177.17% | |
48 Neutral | $36.59M | ― | -37.15% | ― | -0.26% | 60.09% | |
38 Underperform | $104.04M | ― | 0.00% | ― | ― | ― | |
$39.61M | ― | -131.58% | ― | ― | ― | ||
39 Underperform | $48.01M | ― | -82.81% | ― | -92.95% | -50.02% |